House Rep. Dan Maffei (D-N.Y.) this week introduced a new bill that seeks to repeal the 2.3% medical device tax, making up for the $30 billion in lost revenue by cutting tax breaks for big oil and gas companies. The proposed pay-for may to be more popular with Democrats...
A medical device industry analyst says Abbott Laboratories is unlikely to win approval anytime soon for its device used to repair heart valve problems, following a tepid endorsement by government experts. A Food and Drug Administration panel of heart experts voted 5-3 on Wednesday that the...
Leading U.S. Pulmonologists to Investigate Impact of Mauna Kea Technologies' Cellvizio on Lung Cancer DiagnosisMarch 21, 2013 12:45 pm | by The Associated Press | News | Comments
Mauna Kea Technologies (NYSE Euronext: MKEA), leader in the optical biopsy market and developer of Cellvizio®, the fastest way to see cancer, announced today that it has launched a registry study to determine the impact of Cellvizio optical biopsies on the diagnosis of lung cancer, the leading cause of cancer death in the world.
A duo of House Energy & Commerce Committee Republicans announced this week that they plan to take a closer look at the FDA's life sciences initiatives, suggesting that the agency may need an advisory panel to watch its performance. Reps. Michael Burgess (R-Texas) and Joe Pitts (R-Pa.) committed to taking a stronger hand in oversight of the FDA.
ARGO Medical Technologies’ ReWalk exoskeleton was one of the cutting-edge Israeli inventions demonstrated to President Barack Obama in Israel during his visit to a session hosted by Technion-Israel Institute of Technology. ReWalk inventor Dr. Amit Goffer, an alumni of the Technion, is a quadriplegic who was inspired to invent the exoskeleton device because of his own personal story and experience.
Mitek Sports Medicine, a leading developer and manufacturer of orthopaedic sports medicine products and soft tissue repair devices, has launched the MILAGRO Advance Interference Screw, a new biocomposite screw designed to offer easier and faster insertion when compared to traditional interference screws.
Intermountain Medical Center Uses SynCardia Total Artificial Heart to Bridge 31-Year-Old Father to a Heart TransplantMarch 21, 2013 11:24 am | by SynCardia Systems | News | Comments
SynCardia Systems announced today that Andrew Weaver, a 31-year-old husband and father of one who arrived at Intermountain Medical Center in Salt Lake City in grave condition, has been successfully bridged to a heart transplant with the SynCardia temporary Total Artificial Heart and discharged home.
The Healthcare Delivery Institute is a multi-disciplinary organization that includes more than 20 research teams at WPI, external healthcare providers, and industry partners, all working to address the national and global challenge of creating the future of healthcare delivery.
Medical Device Firm iTraumaCare Receives European Union CE Marking for iTClampTM Hemorrhage Control SystemMarch 21, 2013 10:40 am | by The Associated Press | News | Comments
SAN ANTONIO--(BUSINESS WIRE)--Mar 21, 2013--iTraumaCare, an early-stage medical device firm focused on developing traumatic injury solutions for first responder and military medicine applications, has achieved its second regulatory milestone. The company received CE Mark approval to market its...
Ruland has developed a new shaft collar for high pressure washdown applications. Washdown shaft collars are a patent pending design containing a 303 stainless steel shaft collar, male and female shrouds made from FDA compliant materials, and three O-rings with FDA compliant lubrication.
Reell “RT Series” friction positioning hinges introduce uniquely engineered constant torque solutions to precisely control and hold the angle of mounted components in any position.
Functional Characteristics of Antitumor T Cells Change With Increasing Time After Therapeutic TransferMarch 21, 2013 10:00 am | by AACR | News | Comments
Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time. The data, which are published in Cancer Discovery, a journal of the American Association for Cancer Research, highlight the need for new strategies to sustain antitumor T cell functionality to increase the effectiveness of this immunotherapeutic approach.
EarlySense Granted United States Patent for Respiratory Trend Analysis Capability for Contact-Free, Patient Safety Monitoring SystemMarch 21, 2013 7:00 am | by The Associated Press | News | Comments
WALTHAM, Mass.--(BUSINESS WIRE)--Mar 21, 2013--EarlySense, the market leader in Proactive Patient Care Solutions™, announced today that the company has been granted a United States patent for the respiratory trend analysis component of its contact-free, patient safety monitoring system. The...
LYON, France--(BUSINESS WIRE)--Mar 21, 2013--The MEDICREA group, listed on Alternext by NYSE Euronext Paris, a medical company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, announced today the FDA approval of the...
33rd Annual ISICEM Conference Symposium Features Breakthrough Clinical Results Supporting OptiScanner™ from OptiScan BiomedicalMarch 21, 2013 3:00 am | by PR Newswire | News | Comments
BRUSSELS, Belgium, March 21, 2013 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the OptiScanner™, the company's first-of-its-kind automated, bedside glucose...